Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients

Breast J. 2019 May;25(3):545-547. doi: 10.1111/tbj.13275. Epub 2019 Apr 10.

Authors

Armen Soukiazian¹, David G Hicks², Bradley M Turner²

Affiliations

¹ University of Rochester, Rochester, New York.
² Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.

PMID: 30972823
DOI: 10.1111/tbj.13275

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
Algorithms
Breast Neoplasms / drug therapy
Breast Neoplasms / genetics
Breast Neoplasms / metabolism
Breast Neoplasms / pathology*
Female
Follow-Up Studies
Gene Expression Profiling
Humans
Lymph Nodes / pathology
Middle Aged
Neoplasm Recurrence, Local / genetics
Neoplasm Recurrence, Local / pathology*
Prognosis
Receptors, Estrogen / metabolism*
Receptors, Progesterone / metabolism
Young Adult

Substances

Receptors, Estrogen
Receptors, Progesterone